Tsuyoshi Nakamaki

4.5k total citations
94 papers, 2.1k citations indexed

About

Tsuyoshi Nakamaki is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Tsuyoshi Nakamaki has authored 94 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 31 papers in Oncology and 28 papers in Molecular Biology. Recurrent topics in Tsuyoshi Nakamaki's work include Acute Myeloid Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (16 papers) and Retinoids in leukemia and cellular processes (12 papers). Tsuyoshi Nakamaki is often cited by papers focused on Acute Myeloid Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (16 papers) and Retinoids in leukemia and cellular processes (12 papers). Tsuyoshi Nakamaki collaborates with scholars based in Japan, United States and Switzerland. Tsuyoshi Nakamaki's co-authors include H. Phillip Koeffler, Seisho Takeuchi, Masaaki Shiohara, Shigeru Tomoyasu, Hiroshi Kawabata, Roberta Morosetti, Rasha S. Germain, Rong Yang, Jonathan Said and HP Koeffler and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Tsuyoshi Nakamaki

92 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tsuyoshi Nakamaki Japan 23 1.0k 905 630 351 290 94 2.1k
A Tobler Switzerland 26 1.0k 1.0× 806 0.9× 550 0.9× 394 1.1× 420 1.4× 70 2.3k
Miron Prokocimer Israel 22 1.2k 1.2× 860 1.0× 551 0.9× 342 1.0× 217 0.7× 60 2.3k
Yoshihiro Hatta Japan 23 828 0.8× 848 0.9× 654 1.0× 367 1.0× 456 1.6× 159 2.3k
Hirohiko Shibayama Japan 25 1.0k 1.0× 463 0.5× 783 1.2× 501 1.4× 495 1.7× 123 2.2k
Jean Chappel United States 24 1.4k 1.4× 742 0.8× 294 0.5× 100 0.3× 546 1.9× 35 2.3k
Tadashi Nagai Japan 23 976 1.0× 348 0.4× 716 1.1× 966 2.8× 327 1.1× 115 2.4k
Motoshi Ichikawa Japan 25 1.3k 1.3× 343 0.4× 1.1k 1.8× 373 1.1× 634 2.2× 102 2.6k
Terri L. Towers United States 7 1.0k 1.0× 1.2k 1.3× 337 0.5× 341 1.0× 1.6k 5.5× 7 3.6k
Ulrike Heider Germany 32 1.6k 1.6× 1.4k 1.5× 1.2k 1.9× 196 0.6× 207 0.7× 70 2.8k
Philippe Guardiola France 26 737 0.7× 336 0.4× 1.1k 1.7× 500 1.4× 442 1.5× 61 2.3k

Countries citing papers authored by Tsuyoshi Nakamaki

Since Specialization
Citations

This map shows the geographic impact of Tsuyoshi Nakamaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuyoshi Nakamaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuyoshi Nakamaki more than expected).

Fields of papers citing papers by Tsuyoshi Nakamaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsuyoshi Nakamaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuyoshi Nakamaki. The network helps show where Tsuyoshi Nakamaki may publish in the future.

Co-authorship network of co-authors of Tsuyoshi Nakamaki

This figure shows the co-authorship network connecting the top 25 collaborators of Tsuyoshi Nakamaki. A scholar is included among the top collaborators of Tsuyoshi Nakamaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuyoshi Nakamaki. Tsuyoshi Nakamaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hattori, Norimichi, Yohei Sasaki, Yuta Baba, et al.. (2019). Refined Disease Risk Index for Hematological Malignancies, Including Rare Disorders, After Allogeneic Stem Cell Transplantation. Transplantation Proceedings. 51(10). 3437–3443. 7 indexed citations
2.
Arai, Nana, Yuta Baba, Hirotsugu Ariizumi, et al.. (2019). Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia. International Journal of Hematology. 109(5). 539–544. 24 indexed citations
3.
Nakamaki, Tsuyoshi, Yuta Baba, Nana Arai, et al.. (2018). Association of Soluble Interleukin-2 Receptor and C-Reactive Protein with the Efficacy of Bendamustine Salvage Treatment for Indolent Lymphomas and Mantle Cell Lymphoma. Acta Haematologica. 139(1). 12–18. 2 indexed citations
4.
Nakamaki, Tsuyoshi, Kunihiko Fukuchi, Hirotsugu Ariizumi, et al.. (2012). CD20 gene deletion causes a CD20‐negative relapse in diffuse large B‐cell lymphoma. European Journal Of Haematology. 89(4). 350–355. 11 indexed citations
5.
Shiozawa, Eisuke, Masafumi Takimoto, Hirotsugu Ariizumi, et al.. (2010). Primary Pulmonary Classical Hodgkin Lymphoma with Two Recurrences in the Mediastinum : A Case Report. Journal of Clinical and Experimental Hematopathology. 50(2). 151–157. 9 indexed citations
6.
Hattori, Norimichi, et al.. (2009). Over‐expression of CCL3  MIP‐1α in a blastoid mantle cell lymphoma with hypercalcemia. European Journal Of Haematology. 84(5). 448–452. 7 indexed citations
7.
Saito, Bungo, et al.. (2008). [Splenic irradiation as a successful treatment for an elderly patient with B-cell prolymphocytic leukemia].. PubMed. 49(12). 1619–22. 1 indexed citations
8.
Hattori, Norimichi, et al.. (2007). ACUTE PROMYELOCYTIC LEUKEMIA IN THE FIRST TRIMESTER OF PREGNANCY. 67(1). 92–97. 1 indexed citations
9.
Shiozawa, Eisuke, Bungo Saito, Reiko Makino, et al.. (2007). Senile EBV‐associated B‐cell lymphoproliferative disorder of indolent clinical phenotype with recurrence as aggressive lymphoma. Pathology International. 57(10). 688–693. 9 indexed citations
10.
Saito, Bungo, et al.. (2006). Reversible posterior leukoencephalopathy syndrome after repeat intermediate‐dose cytarabine chemotherapy in a patient with acute myeloid leukemia. American Journal of Hematology. 82(4). 304–306. 32 indexed citations
11.
Saito, Bungo, Tsuyoshi Nakamaki, Daisuke Adachi, Junko Suzuki, & Shigeru Tomoyasu. (2004). Acute Respiratory Distress Syndrome during the Third Infusion of Rituximab in a Patient with Follicular Lymphoma. International Journal of Hematology. 80(2). 164–167. 16 indexed citations
12.
Matsuda, Isao, et al.. (2003). [Acute myeloid leukemia originating from the same leukemia clone after the complete remission of acute lymphoid leukemia].. PubMed. 44(9). 946–51. 1 indexed citations
13.
Nakamaki, Tsuyoshi, Junichi Hisatake, Akihiro Yokoyama, et al.. (2003). Elevated levels of cyclin A1 and A (A2) mRNA in acute myeloid leukaemia are associated with increased survival. British Journal of Haematology. 123(1). 72–80. 10 indexed citations
14.
15.
Fukuchi, Kunihiko, et al.. (1998). DNA damage induces p21 protein expression by inhibiting ubiquitination in ML-1 cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1404(3). 405–411. 22 indexed citations
16.
Shiohara, Masaaki, Konstantin S. Spirin, Said Jw, et al.. (1996). Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies.. PubMed. 10(12). 1897–900. 21 indexed citations
17.
Yamada, Kazunari, Tsuyoshi Nakamaki, Akiko Yokoyama, et al.. (1993). [Sideroblastic anemia preceded by essential thrombocythemia with 20q- chromosome abnormality].. PubMed. 34(9). 1027–32. 1 indexed citations
18.
19.
Sakashita, Akihiko, Tsuyoshi Nakamaki, Nanae Tsuruoka, Yoshiaki Honma, & Motoo Hozumi. (1991). Granulocyte colony-stimulating factor, not granulocyte-macrophage colony-stimulating factor, co-operates with retinoic acid on the induction of functional N-formyl-methionyl-phenylalanine receptors in HL-60 cells.. PubMed. 5(1). 26–31. 38 indexed citations
20.
Nakamaki, Tsuyoshi, Akiko Sakashita, Kazuo Suzuki, et al.. (1990). Difference in effects of interferon-α and interferon-γ on the induction of differentiation of retinoic acid-treated acute myeloid leukemia cells in primary culture. Leukemia Research. 14(9). 785–794. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Tobler Breakdown of academic impact, for papers by Miron Prokocimer Breakdown of academic impact, for papers by Yoshihiro Hatta Breakdown of academic impact, for papers by Hirohiko Shibayama Breakdown of academic impact, for papers by Jean Chappel Breakdown of academic impact, for papers by Tadashi Nagai Breakdown of academic impact, for papers by Motoshi Ichikawa Breakdown of academic impact, for papers by Terri L. Towers Breakdown of academic impact, for papers by Ulrike Heider Breakdown of academic impact, for papers by Philippe Guardiola
Rankless by CCL
2026